In-Depth Review: The Future of Health and AgingReview ArticleInfrastructure and resources for an aging population: embracing complexity in translational research
Introduction
During the past 2 centuries, median life expectancy in humans has increased markedly from about age 45 to nearly age 80. It is generally agreed that most of this gain has come from improved sanitation, public health measures (eg, workplace safety), and advances in treating/preventing infections. However, during the past 50 years, remarkable medical advances for prevalent causes of middle-age mortality such as cardiovascular disease and many types of cancer have also played a role. These developments have resulted in rapidly increasing populations of older adults in all industrialized nations. For example, by 2030, approximately 1 in 5 Americans will be 65 years or older (Fig 1). This trend is occurring in developing countries as well, and at a much faster rate than occurred in Europe and the United States. United Nations aging statistics suggest more people age 80 years and older will live in developing than in developed countries by 2025.2
As medical interventions have reduced death rates from acute illness there has been an increasing population living, and aging, with accumulated chronic illnesses. Many older adults experience multiple chronic conditions, which increases the risk of functional limitation and dependency.3, 4 It is, of course, much more expensive to care for those with multiple chronic conditions, and older adults account for the vast majority of health care expenditures as a result of their higher burden of illness and disability.
Despite marked increases in median life span, the maximum human life span has remained essentially constant at just more than 100 years. This realization has led to the concept of “healthspan”—the period of time one spends in healthy, active life before the occurrence of chronic conditions, functional limitation, dependency, or death (reviewed by Kirkland5). Extending healthspan rather than focusing just on life span has become a major goal of gerontology and geriatric research. Focusing on healthspan may have a greater impact on health care cost than addressing life span extension only. Surviving one illness essentially means we live to experience another illness and another and another, increasing the lifetime cost of health care for an individual. However, improving healthspan has the potential to be markedly cost-saving if one can push severe, debilitating illnesses to the very end of life, reducing the time one requires high-cost, labor-intensive care and support.
Of course, the goal of most biomedical research is to expand both healthspan and life span. From this dual viewpoint, aging research dwarfs the potential payback of research focused on any single disease. For example, the average life span of a 50-year-old human in the developed world is about 31 additional years. Because age is such a strong risk factor for multiple illnesses across many organ systems, addressing aging itself has a much greater benefit for extending life span, and certainly healthspan, than curing cancer, heart disease, diabetes mellitus, stroke, or any one illness.5 Thus, investing in aging research is likely to pay dividends in both life span and healthspan—and at least rivals, if not exceeds, the impact of research aimed at cure or prevention of specific diseases. Despite these strong arguments, aging research is often a difficult “sell” to the public, public/elected officials, or even the scientific community for support.
This article describes the state of the current workforce and infrastructure available for translational research in aging, and suggests important changes that are required to further translational research in aging and the care of older adults. It is imperative that isolated illness be studied in the most appropriate models, that multimorbidity be included explicitly rather than excluded, and that outcomes of value to older adults (eg, functional independence, quality of life), not just survival, be primary end points for translational aging research. Although convincing the public of this need is an essential, long-term goal, it is more important in the short term to engage the scientific community and advance a change in the culture to one that embraces complexity—the key element, in my opinion, needed to advance aging research across the translational continuum.
Last, two key aspects of research infrastructure are not part of this review. Research funding is, of course, required to address the issues outlined, but the economics of research funding and priority setting go beyond the scope of this review. Similarly, critical end-of-life issues are also entwined integrally in aging research, but palliative care and end-of-life research is a separate, although related, standing area of research that requires more space than is available within this review. Both issues, frankly, are also outside my expertise, and thus this review focuses on the common issues outlined in the previous paragraph.
Section snippets
Declining numbers of physicians entering geriatrics
Despite the tremendous need for geriatricians, there has been a precipitous decline in physicians becoming certified in geriatric medicine (Fig 2). This is a result, in part, of the elimination of a practice pathway that allowed practicing physicians to become certified without completing fellowship training. More concerning, however, is the continuing lack of interest in graduating students and residents in geriatric medicine. Fig 2 shows the large gap between the number of geriatricians
Animal resources
There are a number of important animal resources for aging research primarily maintained and catalogued by the NIA. A number of rodent resources are available, including mice and rats across the age spectrum of various strains, F1 crosses, and calorie-restricted animals (Table I). In addition, a tissue bank of specimens is available. All investigators with an aging-focused grant are eligible to access these resources, but pricing and priority access vary depending on availability of
Tools and Toolboxes
The NIH Toolbox is a recently released, multidimensional set of brief measures assessing cognitive, emotional, motor, and sensory function across the life span from ages 3–85. The underlying principle leading to the NIH Toolbox was a need for a standard set of measures that could be used across diverse study designs and settings to assess neurologic and behavioral function over time. This facilitates the study of functional changes across the life span, including evaluating intervention and
Embracing Complexity
If there is a single word that separates aging research from other types of translational research it would probably be complexity. As previously noted, the typical older adult rarely presents with a single disease, and often does not even have a predominant illness. More often than not, multiple chronic conditions are present. This conflicts with the general paradigm for biomedical research—isolating a single factor, mechanism, or disease to ensure that any intervention or experimental result
Conclusions
There is a large and growing population of older adults who experience disproportionately illness, declining function, and disability, and consume the majority of health care resources. If we are to respond appropriately to the challenge of providing the most effective and efficient health care for this group of adults, we need to address common obstacles that limit the applicability of the current research paradigm and allow a new paradigm not only to emerge, but also to flourish (Table II).
Acknowledgments
Conflicts of Interest: The author serves on the National Institute of Aging Council, but the opinions and impressions expressed are those of him alone. K. High has no financial or personal relationships with organizations that could potentially be perceived as influencing the described research, and has read the journal's policy on disclosure of potential conflicts of interest.
K. High is supported by National Institutes of Health grants P30 AG021332 and U13 AG040938, and grants from The John A.
References (53)
Translating advances from the basic biology of aging into clinical application
Exp Gerontol
(2013)- et al.
Expanding geriatrics into subspecialty internal medicine healthcare, research and education: caring for older adults and the T. Franklin Williams Career Development Awards
Am J Med
(2002) - et al.
An evaluation of geriatrics activities within internal medicine subspecialties
Am J Med
(2006) - et al.
Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach
Adv Surg
(2010) - et al.
Solid-organ transplantation in older adults: current status and future research
Am J Transplant
(2012) - et al.
Age-related degenerative functional, radiographic, and histological changes of the shoulder in nonhuman primates
J Shoulder Elbow Surg
(2013) - et al.
Workshop on idiopathic pulmonary fibrosis in older adults
Chest
(2010) - ...
- ...
Older Americans
(2012)
Key indicators of well-being
Retooling for an aging America: building the health care workforce
Keeping granny safe on July 1: a consensus on minimum geriatrics competencies for graduating medical students
Acad Med
Medicine in the 21st century: recommended essential geriatrics competencies for internal medicine and family medicine residents
J Grad Med Educ
Treating our societal scotoma: the case for investing in geriatrics, our nation's future, and our patients
Ann Intern Med
Paul B. Beeson Career Development Awards in Aging Research and U.S. medical schools aging and geriatric medicine programs
J Am Geriatr Soc
A preliminary analysis of the effectiveness of the Paul B. Career Development Awards in Aging Initiative, 2004–2006
The Jahnigen scholars program: a model for faculty career development
J Am Geriatr Soc
Developing quality indicators for elderly surgical patients
Ann Surg
Identification and characterization of a functional mitochondrial angiotensin system
Proc Natl Acad Sci U S A
Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores
J Am Geriatr Soc
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis
J Am Geriatr Soc
Pretransplant physical activity predicts all-cause mortality in kidney transplant recipients
Am J Nephrol
Cited by (8)
Multimorbidity in Older Adults With Cardiovascular Disease
2018, Journal of the American College of CardiologyCitation Excerpt :A targeted set of pertinent data elements can be measured longitudinally in a large real-world population to ascertain the impact of various risk factors, multimorbidity, and geriatric syndromes on clinical and/or holistic outcomes (e.g., function, cognition, independence) or in respect to a specific intervention. To that end, very large and comprehensive “big data” networks representative of broad populations have been or are in the process of being generated by CMS, the Veterans Administration, National Institutes of Health (NIH) Health Care Systems Research Collaboratory and a Patient-Centered Outcomes Research Institute (PCORI) data network, (PCORnet), or by pooling electronic health records from multiple health systems (Healthcare Systems Research Network) (52,53). However, standardized metrics of multimorbidity, as well as validated measurements of physical and cognitive function, health-related quality of life, activities of daily living, geriatric syndromes (particularly frailty) (54,55), independence, self-efficacy, and other patient-oriented factors pertinent to older adults are still being refined.
Einstein, the Blind Men, and the Elephant: Making Sense of Heart Failure With Preserved Ejection Fraction
2016, Journal of Cardiac FailureTranslational research on aging: Clinical epidemiology as a bridge between the sciences
2014, Translational ResearchGeriatric Activation Program Pellenberg, a novel physiotherapy program for hospitalized patients on a geriatric rehabilitation ward
2021, Physiotherapy Research International